Outcomes with Single-Agent Gilteritinib for Relapsed or Refractory FLT3-mutant AML after Contemporary Induction Therapy
Jad Othman, Angela Hwang, Maximillian Brodermann, Islam Abdallah, Kayleigh Mccloskey,Paolo Gallipoli, Georgina Clarke,Raymond Dang,Jennifer Vidler,Pramila Krishnamurthy,Faisal Basheer,Anne-Louise Latif,Renuka Palanicawandar,Tom Taylor, Asra Khan,Victoria Campbell, Francesca Hogan, Alex Kanellopoulos, Kathryn Fleming,Angela Collins, Chris Dalley,Justin Loke,Scott Marshall,David Taussig,Sreetharan Munisamy,Eleana Loizou, Heba Yassin,Mike Dennis, Rui Zhao,Edward Belsham,Duncan Murray, Nicole Fowler, Jenny Nions,Anjum Khan,Rob Sellar,Richard Dillon Blood Advances（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper